NEU neuren pharmaceuticals limited

Ann: DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024, page-24

  1. 576 Posts.
    lightbulb Created with Sketch. 67
    I think we're on the cusp of something big. The market or someone is playing games making the price bounce around, but with our revenue growth, it's only a matter of time before it settles down and reflects our true value. If we were listed in the States, I'd think our valuation would be way north of $40.

    With Neuren, we're talking serious potential for those who are patient. I'm happy to sit tight and let the market do its thing. Sure, it's frustrating with all the ups and downs, but it'll be worth it in the end.

    We've come a long way, and I'm optimistic about our future. To put it into perspective, remember where we were a year ago when the price was $24? Now, we're in a much better position and the cash just keeps pouring in.

    As a two year old...you'd explain it like a bag of lollies .... you've got more now than you did last year, and more are coming your way every month. Sure, there might be someone trying to take your lollies in the playground, but just hold on tight and don't let them!

    I really think we're going to make some people sit up and take notice very soon.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.